Digital health, latest generation medical devices and telemedicine are leading us towards integrated care, where multidisciplinarity, teleconsultation, remote management and interoperability of patient data are increasingly becoming a reality. “Every day we have confirmation of the need to integrate traditional and digital medicine. Only in this way, in fact, will we be able to offer people new therapies and facilitate a multidisciplinary approach to medical science. Thanks to digital medicine, in fact, new ways of communicating are emerging. not only between doctor and patient, but also between doctors and this is a fundamental driving force for both research and treatment “. It is from this consideration by Paivi Kerkola, CEO of Pfizer Italia, that the third ConnAction appointment on November 24th, an event dedicated to ‘Digital technologies for multidisciplinarity and networking among health professionals’, a program of virtual events dedicated to Digital Medicine promoted by Pfizer Healthcare Hub and organized by Healthware Group. Massimo Di Maio, Ao Order Mauriziano, Turin Department of Oncology University of Turin and National Secretary of Aiom opened the discussion between experts, citing a paper recently published in Critical Reviews In Oncology / Hematology that refers to the Aiom Decalogue on recommendations to the oncologist who is treating the patient, who, potentially, may wish to request a “second opinion” and recommendations for professionals who are called to express a “second opinion”. “Be open to the second opinion – reports the expert – it is the patient’s right, but it is also the doctor’s right to share the clinical situation in order to start the best treatment path”. Luca Balzarini, Humanitas Research Hospital and Humanitas University, Chief of Department of Diagnostic Imaging, spoke about the revision of care models that go towards decentralization of assistance and data sharing and for the use of teleconsultation as a multidisciplinary approach. underlined the importance, for example, in its field, of radiogenomics as a multidisciplinary approach. Balzarini also exhibited the innovative teleconsultation experience of Humanitas and Pio X with Vodafone, for the “real time” transfer of patient images and clinical data thanks to broadband (5G). “The clinician does not move, but the images move”, as per the experience of remote management for magnetic resonances between the Humanitas Clinic and the Pio X Clinic in Milan. The protagonists of a session were four startups, who reported on their solutions, carefully selected by Pfizer because they are validated and specific for networking between health professionals. They are Health Hub (Italy), Komed Health (Switzerland), Messagenius (Italy), TonicApp (Portugal).